EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Performance of prototype serological immunoassays for foot-and-mouth disease virus using G-H loop peptides and stabilized virus-like particles

Abdelaziz A Yassin iD, Yvonne Sewell, Anna B Ludi, Alison Burman, Georgina Limon, Madeeha Afzal iD, Daniel Horton, Donald P King iD, Amin S Asfor iD

Microbiology Spectrum · 02.06.2026 · 14 (6)

DOI: 10.1128/spectrum.03514-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 02.06.2026. Verfasst von Abdelaziz A Yassin und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Pirbright Institute, Pirbright, United Kingdom. Hauptthemen laut MEDLINE: Foot-and-Mouth Disease Virus, Foot-and-Mouth Disease, Antibodies, Viral, Peptides. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Department for Environment, Food and Rural Affairs, UK Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inter-serotype cross-reactivity of foot-and-mouth disease (FMD) antibody enzyme-linked immunosorbent assays (ELISAs) can exceed 50%, leading to incorrect serotyping of outbreaks with implications for vaccine selection. In this study, synthetic peptides that mimic the hypervariable G-H loop of FMD viruses (FMDVs) that currently circulate in East Africa (O, A, SAT1, and SAT2) were evaluated as capture antigens in ELISAs (pELISAs). A panel of monovalent bovine sera was tested using these novel assays in parallel with separate ELISAs that utilized stabilized virus-like particles (VLPs). Virus neutralization tests using the same viruses were used to benchmark the status of the sera, which revealed evidence of cross-reactivity for the serotype O and SAT2 antigens (encompassing 2/19 and 3/19 of the heterologous sera, respectively). Equivalent diagnostic serotype sensitivity was observed for prototype peptide and VLP ELISAs for serotype O and SAT1 antigens (86% and 100%, respectively), while there was higher diagnostic serotype sensitivity for the VLP ELISAs targeting serotypes A and SAT2 compared to the corresponding pELISAs (86% vs 71% and 100% vs 86%, respectively). The serotype specificity of these tests ranged from 71% to 79% and 52% to 89% for the pELISA and VLP ELISA formats, respectively. Peptides offer a simple, biosafe, and cost-effective approach to present FMDV-specific epitopes, and these initial findings suggest that peptide ELISAs could be a promising approach to develop serological ELISA assays to present authentic epitopes in comparison to ELISAs that use full capsid VLPs. IMPORTANCE This study marks a significant advancement in the development of safe, affordable, and scalable diagnostic tools for foot-and-mouth disease virus. By employing the G-H loop, a critical epitope on the receptor-binding domain within the viral capsid, we demonstrate that the G-H loop peptide-based ELISAs can effectively mimic and present authentic epitopes as the full virus particles in serological assays. This approach offers several important benefits: enhanced biosafety is achieved by eliminating the need for whole virus particles, thereby reducing biosafety risks. Cost-effectiveness : through simplifying antigen production, enabling broader deployment in low and middle income (LMI) regions. Serotype-specific accuracy : tailored antibody ELISAs improve diagnostic accuracy and post-vaccination monitoring. It also improves the sensitivity and specificity when compared to the commercially available kits, which suffer from cross-reactivities (>50% in some cases). The performance of the developed ELISA is comparable to gold-standard virus neutralization tests as a benchmark, which underscores the reliability of the approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Foot-and-Mouth Disease VirusFoot-and-Mouth DiseaseAntibodies, ViralPeptidesAnimalsCattleEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityAntigens, ViralCross ReactionsSerogroupNeutralization TestsVaccines, Virus-Like ParticleCattle Diseases

Stichwörter der Autor:innen

ELISAG-H loopSNTfoot-and-mouth diseasepeptidesvirus-like particle

Substanzen

Antibodies, ViralAntigens, ViralPeptidesVaccines, Virus-Like Particle

Autor:innen und Institutionen

  • The Pirbright Institute, Pirbright, United Kingdom.
  • School of Veterinary Medicine, Department of Comparative Biomedical Sciences, University of Surrey, Guildford, United Kingdom.
  • Department of Foot and Mouth Disease, Veterinary Serum and Vaccine Research Institute, Cairo, Egypt.
  • Animal and Plant Health Agency, Virology Department, Weybridge, United Kingdom.

ORCID-Profile: Abdelaziz A Yassin, Madeeha Afzal, Donald P King, Amin S Asfor

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Department for Environment, Food and Rural Affairs, UK Government

Zitieren

APA

Yassin, A. A., Sewell, Y., Ludi, A. B., Burman, A., Limon, G., Afzal, M., Horton, D., King, D. P., & Asfor, A. S. (2026). Performance of prototype serological immunoassays for foot-and-mouth disease virus using G-H loop peptides and stabilized virus-like particles. Microbiology Spectrum, 14(6). https://doi.org/10.1128/spectrum.03514-25

Vancouver

Yassin AA, Sewell Y, Ludi AB, Burman A, Limon G, Afzal M, et al. Performance of prototype serological immunoassays for foot-and-mouth disease virus using G-H loop peptides and stabilized virus-like particles. Microbiology Spectrum. 2026;14(6). doi:10.1128/spectrum.03514-25

BibTeX
@article{Yassin2026,
  author = {Yassin, Abdelaziz A and Sewell, Yvonne and Ludi, Anna B and Burman, Alison and Limon, Georgina and Afzal, Madeeha and Horton, Daniel and King, Donald P and Asfor, Amin S},
  title = {Performance of prototype serological immunoassays for foot-and-mouth disease virus using G-H loop peptides and stabilized virus-like particles},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1128/spectrum.03514-25}
}
Kostenlos starten →